Elevate your Healthcare opportunity with DON
Guest Speakers at DON virtual event 12th of March 2025
CEO of Cellis AG - Robert Alexanderowiscz
Cellis is a European biotech company, with a focus in cell-based oncology therapy. We have developed a breakthrough platform technology called Macrophage Drug Conjugate (MDC) for the treatment of solid tumors.
.jpg/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:800,cg:true)
CEO of Valanx Bio - Michael Lukesch
Through the power of synthetic biology and genetic code expansion we have developed a novel site-specific protein conjugation platform that allows precise control over conjugation site and number of conjugations on the protein of interest. Based on this platform we are developing a number of cutting-edge biologics towards potential treatments for various indications.
CEO of Preci Health - Shy Zyman
Preci-HealthTM is revolutionizing the landscape of medical care by providing accessible, safe and virtually painless
solutions for blood sampling and injections – anytime, anywhere. Our vision is to ensure every individual has the tools needed to manage their health
with unprecedented accuracy and ease – ultimately, leading to informed decision making and improved healthcare outcomes.
DON Healthcare will be attending
Fierce JPM Week January 14th & 15th, 2025
With a new U.S. president, fresh regulations, and shifting deal trends, 2025 is set to be a transformative year for biopharma and healthcare. At Fierce JPM Week 2025, industry leaders will come together to explore what’s next. From market analysis to an examination of evolving regulatory landscapes, this event will provide expert insights into the opportunities and pressing challenges shaping the future of pharma, biotech, and healthcare.